Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Clinical Characteristics, Healthcare Utilization, and Treatment Patterns Among People Living with HIV by Antiretroviral Therapy Use in the USA, 2021-2024.
Journal: Infectious diseases and therapy
Published: February 05, 2026
Analytical treatment interruption as a tool in the evaluation of immune-mediated interventions for long-term antiretroviral-free control of HIV-1 among people with HIV.
Journal: Contemporary clinical trials
Published: June 18, 2025
Safety, Pharmacokinetics, and Pharmacodynamics of Single-Dose Programmed Cell Death Protein 1 Inhibitor, Budigalimab, in People With HIV-1 With Antiretroviral Therapy-Suppressed Viral Load.
Journal: The Journal of infectious diseases
Published: June 03, 2025
Leronlimab Treatment for Multidrug-Resistant HIV-1 (OPTIMIZE): A Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: August 29, 2024
A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19.
Journal: Clinical therapeutics
Published: April 24, 2024
Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses.
Journal: JHEP reports : innovation in hepatology
Published: August 17, 2023
Bictegravir/emtricitabine/tenofovir alafenamide plus doravirine in highly treatment-experienced men with multidrug-resistant HIV.
Journal: AIDS (London, England)
Published: March 17, 2023
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B.
Journal: Antiviral therapy
Published: November 16, 2022
Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species.
Journal: PLoS pathogens
Published: November 23, 2021
Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection.
Journal: Journal of hepatology
Published: November 04, 2021
Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection.
Journal: Journal of hepatology
Published: November 04, 2021
Last Updated: 09/26/2026